Back close

Docking studies on Peperomia pellucida as antidiabetic drug

Publication Type : Journal Article

Publisher : International Journal of Pharmacy and Pharmaceutical Sciences

Source : International Journal of Pharmacy and Pharmaceutical Sciences, Volume 4, Number SUPPL. 4, p.375-376 (2012)

Url : http://www.scopus.com/inward/record.url?eid=2-s2.0-84866340888&partnerID=40&md5=e7e014077cfde0f1dd82bb614454b4f1

Keywords : aldehyde reductase, antidiabetic activity, antidiabetic agent, article, computer model, computer program, molecular docking, Peperomia, Peperomia pellucida, quercetin, yohimbine

Campus : Kochi

School : School of Pharmacy

Department : Mathematics

Year : 2012

Abstract : Molecular docking, the technique employed for predicting and analyzing the interactions between protein receptors and ligands, is now an integral aspect in drug discovery and development area. In spite of various treatment regimens for diabetes, the third leading cause of death, there exist demand for newer molecules. Hence, the present study was aimed to screen the identified constituents of Peperomia pellucida, the traditionally used drug for diabetes, to determine the potent constituent attributing antidiabetic activity using insilico approach. Docking studies on the constituents were carried out using Autodock 4.0 software against the receptor aldose reductase. Analysis of the results clearly indicated yohimbine as the potent bioactive constituent attributing antidiabetic activity and it showed significant activity than the standard, Quercetin.

Cite this Research Publication : Sa Akhila, Aleykutty, N. Ab, and Manju, Pc, “Docking studies on Peperomia pellucida as antidiabetic drug”, International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, pp. 375-376, 2012.

Admissions Apply Now